<DOC>
	<DOCNO>NCT02862223</DOCNO>
	<brief_summary>This open-label study investigate effectiveness Neprinol maintain healthy cardiovascular health overweight obese adult . Subjects take 3 capsule , 3 time per day period 12 week .</brief_summary>
	<brief_title>A Study Investigating Effects Neprinol Study Product Vascular Function</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Healthy male female ≥ 18 ≤ 75 year age . Overweight subject ( BMI ≥ 27 &lt; 30 ) Obese subject ( BMI &gt; 30 ≤ 35 ) Subjects elevate cholesterol . Total cholesterol 240 mg/dL . Subjects elevate inflammation HSCRP ≥ 3 mg/L . Judged Investigator general good health basis medical history . Females child bear potential must agree use appropriate birth control method entire study period . Agree initiate new exercise diet program entire study period . Agree change current diet exercise program entire study period . Understands study procedure sign form provide informed consent participate study authorization release relevant protect health information study investigator . Subjects history congestive heart failure ( classification ) , unstable angina , acute coronary syndrome within past 30 day . Uncontrolled hypertension ( blood pressure ≥ 170/100 mm Hg ) Subjects history gastrointestinal disease surgery affect absorption Subjects peripheral arterial disease Daily use NSAIDs , however 81mg aspirin daily cardio protection allow Daily use antiinflammatory omega3fatty acid dietary supplement 2 week washout allow Use immunosuppressive drug last 12 month ( include steroid biologics ) Any significant GI condition would severely interfere evaluation study product include limited inflammatory bowel disease ( Ulcerative Colitis Chron 's ) , history frequent diarrhea , history surgery weight loss ( include gastric bypass lapband ) , history perforation stomach intestine , gastroparesis , clinically important lactose intolerance Subjects history use diabetic medication prior 4 week study start Subjects history use insulin prior 12 week study start . Any active infection , infection last month require antibiotic , antiviral medication , hospitalization History presence cancer prior two year , except nonmelanoma skin cancer . Subjects history seizure Recent history ( within 12 month ) strong potential alcohol substance abuse . Participation clinical study exposure nonregistered drug product within 30 day prior . Individual condition Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk . Including subject Bed wheelchairbound Untreated unstable Hypothyroidism Subjects active eat disorder include anorexia nervosa , bulimia , and/or obsessive compulsive eating disorder Pregnant , lactating , unwilling use adequate contraception duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Coagulation</keyword>
	<keyword>Circulatory Function</keyword>
	<keyword>Blood Pressure</keyword>
	<keyword>Inflammatory response</keyword>
	<keyword>Blood Glucose</keyword>
	<keyword>Healthy vascular function</keyword>
</DOC>